Development and synthesis of a non-specific immunomodulating peptidomimetic
... half-life. It was established that after three days of cultivation with the peptidomimetic, the number of DCs was 23.07 % higher (p < 0.05) compared with the negative control.
peptidomimetic, immunomodulatory effect, dendritic cells, toxicity, biological activity, pharmacokinetic properties
95-107
10.5922/vestniknat-2026-2-6
Development and prediction of toxicity of a new antiplatelet food peptide
... tract, is non-mutagenic, and non-cytotoxic. This allows it to be recommended as a functional ingredient for specialized food products, provided its effectiveness is confirmed in in vitro experiments.
cyclic peptides, antithrombotic properties, biological activity, toxicity, cytotoxicity
81-88
10.5922/vestniknat-2024-3-6
